Friday's Analysts' Upgrades and Downgrades - TheStreet

CHANGE IN RATINGS

Coca-Cola Enterprises

(CCE)

downgraded at Bernstein to a Market Perform rating as current share price assumes stronger-than-likely growth in operating profits.

Cabot Oil & Gas

(COG) - Get Report

upgraded at FBR to an Outperform rating and raising its target price to $42. Stock is trading at discount to peers and management is considering a share buyback.

PPL

(PPL) - Get Report

upgraded at UBS to Buy rating from Neutral. Price target lifts to $57 from $52, and 2010 EPS estimates rise to $4.90 from $4.25

inVentiv Health

( VTIV) upgraded at Jefferies to Buy rating from Hold. Price target lifts to $42 from $41, and FY 2008 EPS estimates bump to $2.08 from $2.05.

VCA Antech

(WOOF)

upgraded at Jefferies to Buy rating from Hold. Price target lifts to $44 from $43, and FY 2008 EPS estimates jump to $1.73 from $1.59.

STOCK COMMENTS / EPS CHANGES

Aetna

(AET)

number raised at UBS. Price target lifts to $52 from $50, and 2008 EPS estimates upped to $3.85 from $3.78. Reiterates Hold rating.

Black & Decker

( BDK) full-year estimates cut at Deutsche by 13 cents to $6.48 a share to reflect higher-than-expected commodity costs and headwind of China's new VAT recovery policy. Maintained Buy rating.

Boston Properties

(BXP) - Get Report

2007 estimates increased at Goldman to $4.65 from $4.60, after company reported better than expected Q2 results. Upside came from non-recurring items and better operating performance. Maintained Buy rating and $121 target.

Rockwell Collins

(COL)

numbers raised at UBS. Price target upped to $74 from $65, and 2008 EPS estimates bump to $3.90 from $3.85. Reiterates Hold rating.

Crocs

(CROX) - Get Report

target price raised at ThinkEquity to $72 following a substantially better-than-expected quarter. Margins expanded, distribution growing, and sales mix diversifying. Maintained Buy rating.

Goodrich

( GR) numbers raised at UBS. Price target lifts to $73 from $68, and 2008 EPS estimates upped to $4.30 from $4.00. Reiterates Buy rating.

Prologis

(PLD) - Get Report

2007 estimates raised at Goldman to $4.13 from $4.05, following strong Q2 results. Company anticipates development margins in the 25%-27% range during 2007. See benefits from international exposure, with 80% of development pipeline focused internationally. Maintained Buy rating and $72 target.